There is a lot of evidence showed that, ROS leads to the production and progression of tissue damage in MS and stimulating the Nrf2 pathway may be a protecting mechanism in MS’ pathogenesis (Ohl et al., 2016). Here, NFE2L2 is linked to myeloid sarcoma.